DLH Holdings Corporation (NASDAQ:DLHC) Q3 2021 Earnings Conference Call August 5, 2021 10:00 AM ET Company Participants Chris Witty – Investor Relations Adviser Zach Parker – President and Chief Executive Officer Kathryn JohnBull – Chief Financial Officer Conference Call Participants Joe Gomes – NOBLE Capital Brian Kinstlinger – Alliance Global Partners Operator Good day, and welcome to the DLH Holdings Corporation Third Quarter Earnings Conference Call. All participants will be in a listen-only mode. [Oper ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-18492 DLH HOLDINGS CORP. (Exact name of registrant as specified in its charter) New Jersey 22-1899798 (State or other jurisdiction of incorporation ...

DLH Holdings Corp. (NASDAQ:DLHC) Q2 2021 Earnings Conference Call May 6, 2021 11:00 AM ET Company Participants Chris Witty - Investor Relations Advisor Zach Parker - President & Chief Executive Officer Kathryn JohnBull - Chief Financial Officer Conference Call Participants Brian Kinstlinger - Alliance Global Partners Chris Bliska - NOBLE Financial Operator Good day and welcome to the DLH Holdings Fiscal 2021 Second Quarter Earnings Call. All participants will be in a listen-only mode. [Operator Instructions ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-18492 DLH HOLDINGS CORP. | --- | --- | |-------------------------------------------------------------------------------------------------------|--- ...

Financial Performance - The company reported revenue of $57.9 million for Q1 2021, an increase from $52.2 million in the prior year, reflecting a $7 million contribution from the IBA acquisition [21][22] - Operating income was $3.6 million with operating margins improving to 6.3% from 6% in the previous year [23] - Net income was approximately $1.8 million or $0.13 per diluted share, compared to $1.6 million or $0.12 per share last year [24] - EBITDA for Q1 2021 was $5.7 million, representing 9.8% of sales, up from 9.5% in the prior year [25] Business Lines and Market Data - The company experienced stable revenue delivery from labor year-over-year, with expectations for organic growth due to expansions in current programs and new business wins [22] - Approximately 60% of sales in the quarter were derived from Defense and VA markets, with significant contributions from the IBA acquisition [53] - The backlog at the end of the quarter was $665 million, indicating strong revenue visibility [10] Strategic Outlook and Industry Competition - The company anticipates greater opportunities for growth due to the new administration's focus on healthcare technology improvements, particularly in defense and health agencies [13][14] - The company is integrating acquisitions and enhancing service offerings to differentiate itself in the market [14] - There is an increased focus on digital transformation and artificial intelligence within federal agencies, which is expected to drive bidding activity [16] Management Commentary on Operating Environment and Future Prospects - Management expressed optimism about the year ahead, citing a strong proposal environment and active bidding activity [10][19] - The company is addressing pandemic-related challenges by leveraging technology to continue compliance programs with reduced travel [32] - Management expects to return to normal cash flow in Q2 2021, following a backlog in collections during Q1 [47] Other Important Information - The company has a debt position of $77.4 million, up from $70 million at the start of the fiscal year, primarily due to the IBA acquisition [26] - Management expects to achieve debt levels between $50 million and $52 million by the end of fiscal 2021 [50] Q&A Session Summary Question: Impact of compliance program restrictions on revenue - Management indicated that over 90% of compliance-related revenue reductions were due to onsite visit restrictions, but they are working on alternative methodologies to recover some of that revenue [30][32] Question: Opportunities related to pandemic response - Management highlighted a significant increase in bid activity related to public health and life sciences, with a focus on vaccine rollout and telehealth applications [38][40] Question: Transition in key contract payment offices - Management explained that the transition was impacted by the start of the new fiscal year and the continuing resolution, which caused delays in collections [43][46] Question: Expectations for deleveraging and cash flow - Management expects a strong Q2 in terms of cash delivery, with a historical trend of increasing cash flow through the fiscal year [50][47] Question: Growth in Defense and VA markets - Management noted that the contribution from core VA programs grew from 46% to 48% of revenue, indicating strong growth in that segment [57][59]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-18492 | --- | --- | --- | |------------------------------------------------------------------------------------------------------------|-------- ...

Financial Performance and Key Metrics - The company reported revenue of $50.7 million for Q4 2020 and $209.2 million for the fiscal year, representing a year-over-year increase of over 30% [10][11] - Operating income for the year was $13.5 million, with earnings of $0.54 per share, and EBITDA rose to $20.5 million from $13.9 million the previous year [11] - Cash generated from operations was $19.5 million, which was used to pay down $19 million of debt prior to the acquisition of Irving Burton Associates [12][31] Business Line Performance - Revenue for the Health and Human Services segment was down approximately 14% year-over-year, while the VA logistics segment experienced significant growth [28][40] - The company anticipates organic revenue growth in fiscal 2021 due to new COVID-19 contracts and task order timing [27] Market Data and Key Metrics - The company has a record backlog of nearly $700 million, which is expected to provide a strong foundation for future growth [13][30] - The backlog grew over 66% in fiscal 2020, driven by recent acquisitions and organic growth from recompete contracts [30] Company Strategy and Industry Competition - The company is focused on expanding its capabilities in data analytics, artificial intelligence, and secure systems, positioning itself as a leader in healthcare-related technology solutions [25][26] - The management believes that healthcare-related spending will be prioritized under the new administration, leading to greater opportunities for growth [16][17] Management Commentary on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the ongoing pandemic and its impact on business, noting that the company is well-positioned to assist the government in addressing COVID-19 challenges [18][19] - The company expects to see a rebound in business as restrictions are lifted, although it anticipates some delays in new work due to the continuing resolution [42][44] Other Important Information - The company completed the acquisition of Irving Burton Associates for $32 million, enhancing its health IT solutions and credentials [11] - The integration of IBA is progressing well, with no major issues reported [52] Q&A Session Summary Question: What was the impact of pass-through revenues and delays on the top line? - The impact was estimated at $7 million to $8 million for the quarter and full year [34][35] Question: Can you break out the revenue growth in VA and Health and Human Services? - Revenue in the VA segment grew significantly, while Health and Human Services was down about 14% [38][40] Question: How is the integration of Irving Burton going? - The integration is going well, with no major issues and excitement about new business opportunities [49][52] Question: What is the status of accounts receivable? - Accounts receivable increased due to the acquisition and a transition in the dispersing office, but day sales outstanding remains below 60 [46][47] Question: What is the outlook for the Infinibyte Cloud product? - The product is in the implementation phase with existing customers, and there are significant opportunities anticipated in the near future [55][56]

Part I [Business](index=3&type=section&id=Item%201.%20Business) DLH Holdings Corp. provides technology-enabled services primarily to U.S. federal health and human service agencies, with 98% federal revenue - The company derives **98%** of its revenue from U.S. Federal government agencies, with the Department of Veteran Affairs (VA), Department of Health and Human Services (HHS), and the Department of Defense (DoD) being key clients[14](index=14&type=chunk) Revenue by Market (FY2020 vs. FY2019) | Market Focus Area | FY2020 Revenue (in thousands) | FY2020 Percent of Total | FY2019 Revenue (in thousands) | FY2019 Percent of Total | | :--- | :--- | :--- | :--- | :--- | | Defense/VA | $101,656 | 49% | $93,412 | 58% | | Human Services and Solutions | $40,962 | 20% | $40,679 | 25% | | Public Health/Life Sciences | $66,567 | 31% | $26,300 | 17% | | **Total Revenue** | **$209,185** | **100%** | **$160,391** | **100%** | Revenue by Major Customer (FY2020 vs. FY2019) | Customer | FY2020 Revenue (in thousands) | FY2020 Percent of Total | FY2019 Revenue (in thousands) | FY2019 Percent of Total | | :--- | :--- | :--- | :--- | :--- | | Department of Veterans Affairs | $100,204 | 48% | $91,949 | 57% | | Department of Health and Human Services | $95,026 | 45% | $62,000 | 39% | | Other Customers (<10%) | $13,955 | 7% | $6,442 | 4% | | **Total Revenue** | **$209,185** | **100%** | **$160,391** | **100%** | - On September 30, 2020, the company acquired Irving Burton Associates, LLC (IBA) to expand its services in artificial intelligence, IT modernization, and program management, particularly within the Defense Health Agency (DHA) and U.S. Army Medical Research and Development Command (MRDC)[23](index=23&type=chunk) - Total contract backlog increased to approximately **$688.4 million** at September 30, 2020, from **$414.1 million** at September 30, 2019. The 2020 backlog consists of **$121.3 million** funded and **$567.1 million** unfunded[35](index=35&type=chunk)[36](index=36&type=chunk) - The company's revenue is primarily from time and materials contracts (**70%**), followed by cost-reimbursable contracts (**28%**) and firm-fixed-price contracts (**2%**). It holds a prime contractor position on contracts representing **92%** of its revenue[27](index=27&type=chunk)[28](index=28&type=chunk) [Risk Factors](index=9&type=section&id=Item%201A.%20Risk%20Factors) The company faces substantial risks from its high dependence on federal government contracts, acquisitions, debt, and concentrated ownership - **Business & Industry Risks:** The company derives **98%** of its revenue from federal government contracts and is highly dependent on its relationship with the VA and HHS. Risks include government budget changes, contract termination for convenience, competition, and the U.S. government's preference for small or veteran-owned businesses, which could limit prime contracting opportunities[52](index=52&type=chunk)[53](index=53&type=chunk)[57](index=57&type=chunk) - **COVID-19 Risk:** The pandemic poses risks of economic disruption, potential delays in government decision-making, and reduced demand for services if government spending priorities shift. Increased remote work also elevates cybersecurity risks[95](index=95&type=chunk) - **Acquisition Risks:** The company faces challenges in successfully integrating acquired businesses, such as IBA, which could divert management attention and result in unforeseen operating difficulties. There is also a risk of goodwill impairment, which could negatively affect earnings[107](index=107&type=chunk)[109](index=109&type=chunk) - **Indebtedness Risks:** The company's credit agreement requires compliance with financial covenants (e.g., minimum fixed charge coverage ratio, maximum leverage ratio). A failure to comply could lead to default and acceleration of debt repayment. The transition away from LIBOR may also affect debt servicing costs[112](index=112&type=chunk)[113](index=113&type=chunk) - **Corporate Structure & Stock Risks:** A significant concentration of ownership exists, with executive officers, directors, and the largest shareholder (Wynnefield Capital, Inc.) owning approximately **44%** of outstanding common stock, which may deter a change in control[124](index=124&type=chunk) [Unresolved Staff Comments](index=20&type=section&id=Item%201B.%20Unresolved%20Staff%20Comments) The company reports no unresolved staff comments from the SEC - There are no unresolved staff comments[138](index=138&type=chunk) [Properties](index=20&type=section&id=Item%202.%20Properties) DLH operates from leased facilities across seven locations, with its corporate headquarters in Atlanta, Georgia - The company does not own any real estate and operates out of leased facilities. Its corporate headquarters is in Atlanta, Georgia[139](index=139&type=chunk) - For the fiscal year ended September 30, 2020, the company's total lease expense was approximately **$4.2 million**[140](index=140&type=chunk) [Legal Proceedings](index=20&type=section&id=Item%203.%20Legal%20Proceedings) The company is not aware of any pending litigation likely to materially affect its financial results - The Company is not aware of any pending or threatened litigation that it believes is reasonably likely to have a material adverse effect on its results of operations, financial position or cash flows[141](index=141&type=chunk) [Mine Safety Disclosure](index=20&type=section&id=Item%204.%20Mine%20Safety%20Disclosure) This item is not applicable to the company - Not applicable[142](index=142&type=chunk) Part II [Market for Registrant's Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities](index=21&type=section&id=Item%205.%20Market%20For%20the%20Registrant%27s%20Common%20Equity%2C%20Related%20Shareholder%20Matters%20and%20Issuer%20Purchases%20of%20Equity%20Securities) DLHC common stock trades on Nasdaq, with no cash dividends paid or planned, and approximately 1,300 beneficial owners - The company's common stock is traded on The Nasdaq Capital Market under the symbol **"DLHC"**[145](index=145&type=chunk) - The company has never declared or paid cash dividends on its common stock and has no present intention of doing so[145](index=145&type=chunk) - As of September 30, 2020, there were **12,404,406** shares of common stock outstanding, held by an estimated **1,300** beneficial owners[146](index=146&type=chunk) [Selected Financial Data](index=21&type=section&id=Item%206.%20Selected%20Financial%20Data) As a "smaller reporting company," DLH is not required to provide selected financial data - The company is a **"smaller reporting company"** and is not required to provide the information contained in this item[150](index=150&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=21&type=section&id=Item%207.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) FY2020 revenue grew 30.4% to $209.2 million, driven by acquisitions, with net income rising to $7.1 million Consolidated Statement of Operations Summary (FY2020 vs. FY2019) | Metric | FY 2020 (in thousands) | FY 2019 (in thousands) | Change (in thousands) | | :--- | :--- | :--- | :--- | | Revenue | $209,185 | $160,391 | $48,794 | | Income from operations | $13,461 | $9,968 | $3,493 | | Net income | $7,114 | $5,324 | $1,790 | | Diluted EPS | $0.54 | $0.41 | $0.13 | - Revenue for FY2020 increased by **$48.8 million** (**30.4%**) to **$209.2 million**, primarily due to the inclusion of a full year of results from Social & Scientific Systems, Inc. (S3), which was acquired in June 2019[178](index=178&type=chunk) Reconciliation of GAAP Net Income to EBITDA (Non-GAAP) | Metric | FY 2020 (in thousands) | FY 2019 (in thousands) | Change (in thousands) | | :--- | :--- | :--- | :--- | | Net income | $7,114 | $5,324 | $1,790 | | Interest expense, net | $3,441 | $2,473 | $968 | | Provision for taxes | $2,906 | $2,171 | $735 | | Depreciation and amortization | $7,003 | $3,956 | $3,047 | | **EBITDA** | **$20,464** | **$13,924** | **$6,540** | - Cash flow from operations was **$19.5 million** in FY2020. The company used **$32.8 million** in investing activities, primarily for the IBA acquisition, and received **$12.9 million** from financing activities, mainly from its credit facility[193](index=193&type=chunk)[194](index=194&type=chunk)[195](index=195&type=chunk) - As of September 30, 2020, the company had a **$70.0 million** secured term loan and access to a **$25.0 million** revolving line of credit, with **$24.8 million** of unused borrowing capacity[197](index=197&type=chunk)[200](index=200&type=chunk)[201](index=201&type=chunk) - The company believes its key programs benefit from bipartisan support and does not expect a material impact from budget negotiations, though the government was operating under a Continuing Resolution (CR) expiring December 11, 2020[161](index=161&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=31&type=section&id=Item%207A.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company's primary market risk is interest rate fluctuations on variable-rate debt, partially mitigated by a swap - The company's main market risk is interest rate risk. A **1.0%** increase in the LIBOR rate would increase annual interest expense by **$0.2 million**[226](index=226&type=chunk) - To manage interest rate risk, the company entered into a floating-to-fixed interest rate swap with a notional amount of **$36 million**[226](index=226&type=chunk) [Financial Statements and Supplemental Data](index=31&type=section&id=Item%208.%20Financial%20Statements%20and%20Supplemental%20Data) This item refers to the Consolidated Financial Statements starting on page F-1 - This item directs the reader to the Consolidated Financial Statements beginning on page **F-1**[227](index=227&type=chunk) [Changes in and Disagreements With Accountants on Accounting and Financial Disclosure](index=31&type=section&id=Item%209.%20Changes%20in%20and%20Disagreements%20With%20Accountants%20on%20Accounting%20and%20Financial%20Disclosure) The company reports no changes or disagreements with its accountants on financial disclosure - None reported[228](index=228&type=chunk) [Controls and Procedures](index=31&type=section&id=Item%209A.%20Controls%20and%20Procedures) Management concluded disclosure controls and internal control over financial reporting were effective as of September 30, 2020 - The CEO and CFO concluded that the company's disclosure controls and procedures were effective as of the end of the fiscal year[229](index=229&type=chunk) - Management concluded that the company's internal control over financial reporting was effective as of September 30, 2020, based on the COSO framework[234](index=234&type=chunk) - No material changes in internal control over financial reporting occurred during the fourth quarter of fiscal 2020[237](index=237&type=chunk) [Other Information](index=32&type=section&id=Item%209B.%20Other%20Information) No other information is reported for this item - None reported[238](index=238&type=chunk) Part III [Directors, Executive Officers and Corporate Governance](index=33&type=section&id=Item%2010.%20Directors%2C%20Executive%20Officers%20and%20Corporate%20Governance) Information on directors, executive officers, and corporate governance is incorporated by reference from the proxy statement - Information is incorporated by reference from the Company's definitive proxy statement[241](index=241&type=chunk) [Executive Compensation](index=33&type=section&id=Item%2011.%20Executive%20Compensation) Executive compensation information is incorporated by reference from the company's definitive proxy statement - Information is incorporated by reference from the Company's definitive proxy statement[243](index=243&type=chunk) [Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](index=33&type=section&id=Item%2012.%20Security%20Ownership%20of%20Certain%20Beneficial%20Owners%20and%20Management%20and%20Related%20Stockholder%20Matters) Security ownership information is incorporated by reference from the company's definitive proxy statement - Information is incorporated by reference from the Company's definitive proxy statement[244](index=244&type=chunk) [Certain Relationships and Related Transactions, and Director Independence](index=33&type=section&id=Item%2013.%20Certain%20Relationships%20and%20Related%20Transactions%2C%20and%20Director%20Independence) Information on related transactions and director independence is incorporated by reference from the proxy statement - Information is incorporated by reference from the Company's definitive proxy statement[245](index=245&type=chunk) [Principal Accountant Fees and Services](index=33&type=section&id=Item%2014.%20Principal%20Accountant%20Fees%20and%20Services) Principal accountant fees and services information is incorporated by reference from the proxy statement - Information is incorporated by reference from the Company's definitive proxy statement[246](index=246&type=chunk) Part IV [Exhibits and Financial Statement Schedules](index=33&type=section&id=Item%2015.%20Exhibits%20and%20Financial%20Statement%20Schedules) This section lists all financial statements, schedules, and exhibits filed with the Form 10-K report - This section provides a list of all exhibits filed with the Form 10-K, including stock purchase agreements, credit agreements, employment agreements, and required certifications[250](index=250&type=chunk)[252](index=252&type=chunk) [Form 10-K Summary](index=36&type=section&id=Item%2016.%20Form%2010-K%20Summary) No summary is provided under this item - None[256](index=256&type=chunk) Consolidated Financial Statements [Consolidated Statements of Operations](index=39&type=section&id=Consolidated%20Statements%20of%20Operations) FY2020 revenue increased to **$209.2 million** and net income to **$7.1 million**, with diluted EPS at **$0.54** Statement of Operations Highlights | Metric | Year Ended Sep 30, 2020 (in thousands) | Year Ended Sep 30, 2019 (in thousands) | | :--- | :--- | :--- | | Revenue | $209,185 | $160,391 | | Income from operations | $13,461 | $9,968 | | Net income | $7,114 | $5,324 | | Diluted EPS | $0.54 | $0.41 | [Consolidated Balance Sheets](index=40&type=section&id=Consolidated%20Balance%20Sheets) As of September 30, 2020, total assets were **$183.6 million**, total liabilities **$130.1 million**, and shareholders' equity **$53.4 million** Balance Sheet Highlights | Metric | As of Sep 30, 2020 (in thousands) | As of Sep 30, 2019 (in thousands) | | :--- | :--- | :--- | | Total Current Assets | $37,397 | $26,847 | | Goodwill | $67,144 | $52,758 | | Intangible assets, net | $52,612 | $41,208 | | **Total Assets** | **$183,562** | **$129,258** | | Total Current Liabilities | $47,961 | $29,485 | | Total Long-term Liabilities | $82,164 | $54,202 | | **Total Liabilities** | **$130,125** | **$83,687** | | **Total Shareholders' Equity** | **$53,437** | **$45,571** | [Consolidated Statements of Cash Flows](index=41&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) FY2020 net cash from operations was **$19.5 million**, with **$32.8 million** used in investing and **$12.9 million** from financing Cash Flow Summary | Cash Flow Activity | Year Ended Sep 30, 2020 (in thousands) | Year Ended Sep 30, 2019 (in thousands) | | :--- | :--- | :--- | | Net cash provided by operating activities | $19,451 | $18,039 | | Net cash used in investing activities | ($32,830) | ($67,484) | | Net cash provided by financing activities | $12,946 | $44,880 | | **Net change in cash and cash equivalents** | **($433)** | **($4,565)** | [Notes to Consolidated Financial Statements](index=43&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) Notes detail accounting policies, revenue recognition, lease accounting, credit facilities, and business combinations - **Revenue Recognition (Note 5):** Revenue is recognized over time as services are rendered, primarily using a cost-based input method. The majority of contracts are with the U.S. government, which allows for termination for convenience, supporting the over-time recognition model[308](index=308&type=chunk) Disaggregated Revenue by Contract Type (Note 5) | Contract Type | FY 2020 Revenue (in thousands) | FY 2019 Revenue (in thousands) | | :--- | :--- | :--- | | Time and materials | $147,509 | $134,136 | | Cost reimbursable | $58,091 | $23,200 | | Firm fixed price | $3,585 | $3,055 | | **Total Revenue** | **$209,185** | **$160,391** | - **Leases (Note 6):** The company adopted ASC 842 on October 1, 2019, resulting in the recognition of operating lease right-of-use assets of **$17.4 million** and lease liabilities of **$18.0 million** on the balance sheet[285](index=285&type=chunk)[320](index=320&type=chunk) - **Credit Facilities (Note 8):** As of Sep 30, 2020, the company has a **$70.0 million** secured term loan maturing in 2025 with an interest rate of LIBOR + **3.5%** (subject to a **0.5%** floor) and a **$25.0 million** revolving line of credit. The company is in compliance with all financial covenants[345](index=345&type=chunk)[346](index=346&type=chunk) - **Business Combinations (Note 16):** The company acquired Irving Burton Associates, LLC (IBA) on September 30, 2020, for a preliminary net purchase price of **$32.7 million**. The preliminary allocation resulted in goodwill of **$14.4 million** and intangible assets of **$16.2 million**[379](index=379&type=chunk)[339](index=339&type=chunk)[336](index=336&type=chunk)

DLH Holdings Corp. (NASDAQ:DLHC) Q3 2020 Earnings Conference Call August 6, 2020 11:00 AM ET Company Participants Chris Witty – Investor Relations Advisor Zach Parker – President and Chief Executive Officer Kathryn JohnBull – Chief Financial Officer Conference Call Participants Ken Herbert – Canaccord Chris Bliska – NOBLE Capital Operator Good day and welcome to the DLH Holdings Fiscal 2020 Third Quarter Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this e ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-18492 DLH HOLDINGS CORP. (Exact name of registrant as specified in its charter) New Jersey (State or other jurisdiction of incorporation or organiza ...